University of Zurich | GenomeWeb

University of Zurich

Researchers sequenced dozens of Treponema pallidum isolates associated with syphilis, yaws, or bejel to look at the emergence of pandemic syphilis.

The method helps break up the genome by chromosome and reduces the complexity of identifying target genes, which is particularly useful for certain plant genomes.

Authors of a recent study in BMC Research Notes have concluded that archeological control testing and targeted verification testing are key to avoiding false-positive pathogen identification when

NEW YORK (GenomeWeb News) – The Plasmodium vivax parasite species behind most human malaria cases in Asia and Latin America can be traced back to Africa, where some ape species are still frequently afflicted with the parasite, according to a Nature Communications

NEW YORK (GenomeWeb News) – The European Union has approved a project aimed at determining the causes of extreme aggressive behavior and is providing €6 million ($8 million) to the effort.

The study offers scientists a streamlined method for investigating the effects of miRNAs on protein expression and is "quite typical" of the kind of work the ISB and ETH Zurich's SRMAtlas will help facilitate, said Ruedi Aebersold, co-developer of the SRMAtlas.

ISB researchers will use the company's synthetic peptides and HeavyPeptide AQUA standards in their efforts to develop selected-reaction monitoring and multiple-reaction monitoring mass spectrometry assays for each of the roughly 25,000 human proteins.

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.